These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20629912)

  • 1. Indicators of anxiety and depression in women with the fragile X premutation: assessment of a clinical sample.
    Lachiewicz A; Dawson D; Spiridigliozzi G; Cuccaro M; Lachiewicz M; McConkie-Rosell A
    J Intellect Disabil Res; 2010 Jul; 54(7):597-610. PubMed ID: 20629912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis.
    Cronister A; Teicher J; Rohlfs EM; Donnenfeld A; Hallam S
    Obstet Gynecol; 2008 Mar; 111(3):596-601. PubMed ID: 18310361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of triple repeats on the FMR1 (fragile X) gene to ovarian reserve: a new infertility test?
    Gleicher N; Weghofer A; Oktay K; Barad DH
    Acta Obstet Gynecol Scand; 2009; 88(9):1024-30. PubMed ID: 19642041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproductive health of adolescent girls who carry the FMR1 premutation: expected phenotype based on current knowledge of fragile x-associated primary ovarian insufficiency.
    De Caro JJ; Dominguez C; Sherman SL
    Ann N Y Acad Sci; 2008; 1135():99-111. PubMed ID: 18574214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the molecular parameters that could predict the risk of manifesting premature ovarian failure in female premutation carriers of fragile X syndrome.
    Tejada MI; García-Alegría E; Bilbao A; Martínez-Bouzas C; Beristain E; Poch M; Ramos-Arroyo MA; López B; Fernandez Carvajal I; Ribate MP; Ramos F
    Menopause; 2008; 15(5):945-9. PubMed ID: 18427356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of FMR1 gene expression in female premutation carriers using robust segmented linear regression models.
    García-Alegría E; Ibáñez B; Mínguez M; Poch M; Valiente A; Sanz-Parra A; Martinez-Bouzas C; Beristain E; Tejada MI
    RNA; 2007 May; 13(5):756-62. PubMed ID: 17449730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of a clinical checklist in the diagnosis of fragile X syndrome in India.
    Guruju MR; Lavanya K; Thelma BK; Sujatha M; OmSai VR; Nagarathna V; Amarjyothi P; Jyothi A; Anandaraj MP
    J Clin Neurosci; 2009 Oct; 16(10):1305-10. PubMed ID: 19560928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragile X-associated tremor/ataxia syndrome: intrafamilial variability and the size of the FMR1 premutation CGG repeat.
    Capelli LP; Gonçalves MR; Kok F; Leite CC; Nitrini R; Barbosa ER; Vianna-Morgante AM
    Mov Disord; 2007 Apr; 22(6):866-70. PubMed ID: 17290448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diminished ovarian reserve is not observed in infertility patients with high normal CGG repeats on the fragile X mental retardation 1 (FMR1) gene.
    Schufreider A; McQueen DB; Lee SM; Allon R; Uhler ML; Davie J; Feinberg EC
    Hum Reprod; 2015 Nov; 30(11):2686-92. PubMed ID: 26345686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragile X premutation with atypical symptoms at onset.
    Cellini E; Forleo P; Ginestroni A; Nacmias B; Tedde A; Bagnoli S; Mascalchi M; Sorbi S; Piacentini S
    Arch Neurol; 2006 Aug; 63(8):1135-8. PubMed ID: 16908740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinsonism, FXTAS, and FMR1 premutations.
    Toft M; Aasly J; Bisceglio G; Adler CH; Uitti RJ; Krygowska-Wajs A; Lynch T; Wszolek ZK; Farrer MJ
    Mov Disord; 2005 Feb; 20(2):230-3. PubMed ID: 15390127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A neuropsychological investigation of male premutation carriers of fragile X syndrome.
    Moore CJ; Daly EM; Schmitz N; Tassone F; Tysoe C; Hagerman RJ; Hagerman PJ; Morris RG; Murphy KC; Murphy DG
    Neuropsychologia; 2004; 42(14):1934-47. PubMed ID: 15381024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetrance of marked cognitive impairment in older male carriers of the FMR1 gene premutation.
    Sévin M; Kutalik Z; Bergman S; Vercelletto M; Renou P; Lamy E; Vingerhoets FJ; Di Virgilio G; Boisseau P; Bezieau S; Pasquier L; Rival JM; Beckmann JS; Damier P; Jacquemont S
    J Med Genet; 2009 Dec; 46(12):818-24. PubMed ID: 19542082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study.
    Rohr J; Allen EG; Charen K; Giles J; He W; Dominguez C; Sherman SL
    Hum Reprod; 2008 May; 23(5):1220-5. PubMed ID: 18310677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation.
    Hessl D; Tassone F; Loesch DZ; Berry-Kravis E; Leehey MA; Gane LW; Barbato I; Rice C; Gould E; Hall DA; Grigsby J; Wegelin JA; Harris S; Lewin F; Weinberg D; Hagerman PJ; Hagerman RJ
    Am J Med Genet B Neuropsychiatr Genet; 2005 Nov; 139B(1):115-21. PubMed ID: 16184602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of fragile X mental retardation gene 1 CGG repeat sizes in the normal and intermediate range in women with primary ovarian insufficiency.
    Voorhuis M; Onland-Moret NC; Janse F; Ploos van Amstel HK; Goverde AJ; Lambalk CB; Laven JS; van der Schouw YT; Broekmans FJ; Fauser BC;
    Hum Reprod; 2014 Jul; 29(7):1585-93. PubMed ID: 24812319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric disorders among women with the fragile X premutation without children affected by fragile X syndrome.
    Gossett A; Sansone S; Schneider A; Johnston C; Hagerman R; Tassone F; Rivera SM; Seritan AL; Hessl D
    Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1139-1147. PubMed ID: 27615674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragile X founder effects and new mutations in Finland.
    Zhong N; Kajanoja E; Smits B; Pietrofesa J; Curley D; Wang D; Ju W; Nolin S; Dobkin C; Ryynänen M; Brown WT
    Am J Med Genet; 1996 Jul; 64(1):226-33. PubMed ID: 8826481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular/clinical correlations in females with fragile X.
    Sobesky WE; Taylor AK; Pennington BF; Bennetto L; Porter D; Riddle J; Hagerman RJ
    Am J Med Genet; 1996 Aug; 64(2):340-5. PubMed ID: 8844077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variation and intergenerational FMR1 CGG-repeat stability in 100 unrelated three-generation families from the normal population.
    Patsalis PC; Sismani C; Stylianou S; Ioannou P; Joseph G; Manoli P; Holden JJ; Hettinger JA
    Am J Med Genet; 1999 May; 84(3):217-20. PubMed ID: 10331595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.